Partner Sheila Swaroop was quoted in “Generic Drug Decisions Stall as Virus Forces Patent Court Delays,” which was published in Bloomberg Law. Excerpt: The goal has “consistently” been to resolve the litigation within the…
A panel discussion featuring Knobbe Martens Partner, Mauricio Uribe; Pressao Medical’s CEO, Sung Pak; Co-Founder Makani Science, Dr. Michael Chu; and BeeTimer’s CTO, Terry O’Shea. From health and wellness to engineering…
Partner Philip Nelson was quoted in “Q&A: How Do You Protect Your IP?,” which was published in Medical Design Briefs. Excerpt: “How should medical device companies protect their intellectual property (IP)…
Associate Kim Kennedy and Partner Mike Fuller authored “Trade Secrets Or Patents?” which was published in Life Science Leader. Excerpt: Biotechnology companies are in an exceptionally competitive field, with multiple companies competing against…
JD Supra has recognized Knobbe Martens attorneys as “top authors” for contributing popular thought-leadership pieces addressing key legal topics – a repeat honor for the firm. In the publication’s 2020…
Knobbe Martens is pleased to announce that it has obtained a significant trial defense victory for the firm’s longtime client Infantino in an International Trade Commission (ITC) Investigation over alleged…
Summary On April 23, 2020, the U.S. Supreme Court unanimously held in Romag Fasteners Inc. v. Fossil Inc. that a finding of “willfulness” is not required as a precondition to an award…
Knobbe Martens is pleased to announce that the firm has once again been ranked as one of the top law firms in California for intellectual property, life sciences, and patent…
The Decision. On April 20, 2020, the U.S. Supreme Court ruled that decisions by the Patent Trial and Appeal Board (PTAB) to institute inter partes review (IPR) are not appealable, even if…
Partner Irfan Lateef was quoted in, “Patent Filings, Litigation May Shift in Economic Crisis,” an article published by Bloomberg Law. Excerpt: “Companies are facing tough decisions about applying for patents and launching infringement…
